|Mr. Seamus Lagan||CEO, Pres, Interim CFO & Director||587k||N/A||48|
|Ms. Victoria Nemerson Esq.||Gen. Counsel & Exec. VP||N/A||N/A||N/A|
|Ms. Karen Taylor||Director of HR||N/A||N/A||N/A|
|Mr. Sebastien Sainsbury||Company Sec. & CEO of Platinum Financial Solutions, Ltd||N/A||N/A||N/A|
|Dr. Bharat Madireddy Ph.D.||CEO of Rennova Owned Laboratories and COO of Medytox Diagnostics Inc.||N/A||N/A||N/A|
Rennova Health, Inc., together with its subsidiaries, provides a suite of healthcare related products and services to healthcare providers in the United States. The company operates in three segments: Laboratory Services, Supportive Software Solutions, and Decision Support and Informatics Operations. It provides toxicology, clinical pharmacogenetics, and esoteric testing services. The company also offers Advantage, a HIPAA compliant software; Clinlab, a Windows-based Web-enabled laboratory information management system; and Medical Mime, a suite of solutions, which include an optimized Electronic health records (EHR) for substance abuse and behavioral health providers, a dictation-based ambulatory EHR for physician practices, and advanced transcription services. In addition, it develops and markets interpretation and decision support solutions that enhance cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients. Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida.
Rennova Health, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.